Myriad Genetics Inc
(MYGN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2020 | 12-2019 | 06-2019 | 06-2018 | 06-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -199,500 | N/A | 4,600 | 133,300 | 17,400 |
| Depreciation Amortization | 171,700 | N/A | 73,000 | 54,400 | 48,300 |
| Income taxes - deferred | -55,800 | N/A | 18,600 | -23,500 | 800 |
| Accounts receivable | 64,000 | N/A | -18,200 | -9,100 | 500 |
| Accounts payable and accrued liabilities | -10,700 | N/A | 1,100 | 4,000 | -3,000 |
| Other Working Capital | 117,900 | N/A | -39,400 | 8,500 | 5,600 |
| Other Operating Activity | -26,900 | 0 | 44,000 | -51,700 | 36,600 |
| Operating Cash Flow | $60,700 | $N/A | $83,700 | $115,900 | $106,200 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -10,200 | N/A | -8,600 | -8,400 | -6,100 |
| Net Acquisitions | 21,300 | N/A | -278,500 | N/A | -216,100 |
| Purchase Of Investment | -60,800 | N/A | -78,500 | -80,900 | -87,500 |
| Sale Of Investment | 69,000 | N/A | 79,200 | 77,700 | 163,400 |
| Investing Cash Flow | $19,300 | $N/A | $-286,400 | $-11,600 | $-146,300 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | N/A | 199,000 |
| Debt Issued | N/A | N/A | 340,000 | 53,000 | 204,000 |
| Debt Repayment | -8,600 | N/A | -115,000 | -143,000 | -105,000 |
| Common Stock Issued | 13,300 | N/A | 23,200 | 36,900 | 6,000 |
| Common Stock Repurchased | N/A | N/A | -50,000 | N/A | -31,600 |
| Other Financing Activity | -14,700 | 0 | -15,900 | -41,900 | -200,600 |
| Financing Cash Flow | $-10,000 | $N/A | $182,300 | $-95,000 | $71,800 |
| Exchange Rate Effect | 500 | N/A | 2,700 | -800 | 2,200 |
| Beginning Cash Position | 93,200 | N/A | 110,900 | 102,400 | 68,500 |
| End Cash Position | 163,700 | N/A | 93,200 | 110,900 | 102,400 |
| Net Cash Flow | $70,500 | $N/A | $-17,700 | $8,500 | $33,900 |
| Free Cash Flow | |||||
| Operating Cash Flow | 60,700 | N/A | 83,700 | 115,900 | 106,200 |
| Capital Expenditure | -10,200 | N/A | -8,600 | -8,400 | -6,100 |
| Free Cash Flow | 50,500 | 0 | 75,100 | 107,500 | 100,100 |